Hypermagnesemia in CAPD. Relationship with parathyroid hormone levels

Peritoneal Dialysis International

Volumn 18, Issue 1, 1998, Pages 77-80

  Navarro, Juan F ^a   Mora, Carmen ^a   García, Javier ^a   Macía, Manuel ^a   Gallego, Eduardo ^a   Chahin, Jesús ^a   Méndez, María L ^a   Rivero, Antonio ^a  

^a HOSPITAL UNIVERSITARIO NUESTRA SEÑORA DE CANDELARIA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALUMINUM; CALCITRIOL; CALCIUM ION; MAGNESIUM; PARATHYROID HORMONE; PHOSPHORUS;

ADULT; AGED; ARTICLE; BONE TURNOVER; CLINICAL ARTICLE; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; FEMALE; HUMAN; HYPERMAGNESEMIA; MAGNESIUM BLOOD LEVEL; MALE; OSTEITIS FIBROSA; PARATHYROID HORMONE BLOOD LEVEL; PATHOGENESIS; PRIORITY JOURNAL; RENAL OSTEODYSTROPHY;

EID: 0031942175     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: 10.1177/089686089801800111     Document Type: Article

References (28)

1. Llach F, Bover J. Renal osteodystrophy. In: Brenner BM, ed. The kidney. Philadelphia: Saunders, 1996: 2187-273.
2. Sherrard DJ, Hercz G, Pei Y, Maloney NA, Greenwood C, Manuel A, et al. The spectrum of hone disease in end-stage renal failure: an evolving disorder. Kidney Int 1993; 43:436-42.
3. Coburn JW. Mineral metabolism and renal bone disease: effects of CAPD versus hemodialysis. Kidney Int 1993; 43(Suppl 40):92-100.
4. Torres A, Lorenzo V, Hernández D, Rodríguez JC, Concepción MT, Rodríguez AP, et al. Bone disease in predialysis, hemodialysis and CAPD patients: evidence of a better response to PTH. Kidney Int 1995; 47:1434-42.
5. Yamamoto M, Igarashi T, Muramatsu E, Fukagawa M, Motokura T, Ogata E. Hypocalcemia increases and hypercalcemia decreases the steady-state level of parathyroid hormone messenger RNA in the rat. J Clin Invest 1989; 83:1053-6.
6. Naveh-Many T, Silver J. Regulation of parathormone gene expression by hypocalcemia, hypercalcemia and vitamin D in the rat. J Clin Invest 1990; 86:1313-19.
7. Rodríguez M, Almadén Y, Hernández A, Torres A. Effect of phosphate on the parathyroid gland: direct and indirect? Curr Opin Nephrol Hypertens 1996; 5:213-28.
8. Hernández A, Concepción M, Rodríguez M, Salido E, Torres A. High phosphorus diet increases preproPTH mRNA independent of calcium and calcitriol. Kidney Int 1996; 50:1872-8.
9. Slatopolsky E, Finch J, Denda M, Ritter C, Zhong M, Dusso A, et al. Phosphorus restriction prevents parathyroid gland growth. High phosphorus directly stimulates PTH secretion in vitro. J Clin Invest 1996; 97: 2534-40.
10. Brown E. Extracellular calcium sensing, regulation of parathyroid cell function, and role of calcium and other ions as extracellular (first) messengers. Physiol Rev 1991; 71:371-411.
11. Ferment O, Gamier P, Touitou Y. Comparison of the feed-back effect of magnesium and calcium on parathyroid hormone secretion in man. J Endocrinol 1987; 113:117-22.
12. Cholst I, Steinberg S, Tropper P, Fox M, Segre G, Bileziian J. The influence of hypermagnesemia on serum calcium and parathyroid hormone levels in human subjects. N Engl J Med 1984; 310:1221-5.
13. Gough IR, Balderson GA, Lloyd HM, Galligan J, Willgoss D, Fryar BG. The effect of intravenous magnesium sulphate on parathyroid function in primary hyperparathyroidism. World J Surg 1988; 12:463-9.
14. Navarro JF, Macía ML, Gallego E, Méndez ML, Chahin J, García-Nieto V, et al. Serum magnesium concentration and PTH levels. Is long-term chronic hypermagnesemia a risk factor for adynamic bone disease? Scand J Urol Nephrol 1997; 31:275-80.
15. Takahashi S, Okada K, Yanai M. Magnesium and parathyroid hormone changes to magnesium free dialysate in continuous ambulatory peritoneal dialysis patients. Perit Dial Int 1994; 14:75-8.
16. Ejaz AA, McShane AP, Gandhi VC, Leehey DJ, Ing TS. Hypomagnesemia in continuous ambulatory peritoneal dialysis patients dialyzed with a low-magnesium peritoneal dialysis solution.Perit Dial Int 1995; 15:61-4.
17. Hutchinson AJ, Were AJ, Boulton HF, Mawer EB, Laing I, Gokal R. Hypercalcaemia, hypermagnesaemia, hyperphosphataemia and hyperaluminaemia in CAPD: Improvement in serum biochemistry by reduction in dialysate calcium and magnesium concentrations. Nephron 1996; 72:52-8.
18. Blumenkrantz MJ, Kopple JD, Moran JK, Coburn JW. Metabolic balance studies and dietary protein requirements in patients undergoing continuous peritoneal dialysis. Kidney Int 1982; 21:849-61.
19. Delmez JA, Slatopolsky E, Martin KJ, Gearing BN, Haster HR. Mineral, vitamin D and parathyroid hormone in continuous ambulatory peritoneal dialysis. Kidney Int 1982; 21:862-7.
20. Buckle R, Care A, Cooper C, Gitelman H. The influence of plasma magnesium concentration on parathyroid hormone secretion. J Endocrinol 1968; 42:529-34.
21. Massry SG, Coburn JW, Kleeman CR. Evidence for supression of parathyroid gland activity by hypermagnesemia. J Clin Invest 1970; 49:1619-29.
22. Wallace J, Scarpa A. Regulation of parathyroid hormone secretion in vitro by divalent cations and cellular metabolism. J Biol Chem 1982; 257:10613-16.
23. Brown E. Extracellular calcium sensing, regulation of parathyroid cell function, and role of calcium and other ions as extracellular (first) messengers. Physiol Rev 1991; 71:371-411.
24. Pletka P, Bernstein DS, Hampers CL, Merrill JP, Sherwood LM. Relationship between magnesium and secondary hyperparathyroidism during long-term hemodialysis. Metabolism 1974; 23:619-30.
25. Pei Y, Hercz G, Greenwood C, Segre G, Manuel A, Saiphoo C, et al. Risk factors for renal osteodystrophy: a multivariant analysis. J Bone Miner Res 1995; 10:149-58.
26. Hercz G, Pei Y, Greenwood C, Manuel A, Shaipoo C, Goodman WG, et al. Aplastic osteodystrophy without aluminum: the role of suppressed parathyroid function. Kidney Int 1993; 44:860-6.
27. Fournier A, Hardy P, Hué P, Said S, Hamdini N, Eldin HM, et al. Adynamic bone disease in patients with uremia.Curr Opin Nephrol Hypertens 1994; 3:396-410.
28. Hutchinson AJ, Moore PR. Low turnover bone disease. Perit Dial Int 1996; 16(Suppl 1):295-9.